These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 30135556)

  • 1. Do baseline sub-threshold hypomanic symptoms affect acute-phase antidepressant outcome in outpatients with major depressive disorder? Preliminary findings from the randomized CO-MED trial.
    Jha MK; Malchow AL; Grannemann BD; Rush AJ; Trivedi MH
    Neuropsychopharmacology; 2018 Oct; 43(11):2197-2203. PubMed ID: 30135556
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combining medications to enhance depression outcomes (CO-MED): acute and long-term outcomes of a single-blind randomized study.
    Rush AJ; Trivedi MH; Stewart JW; Nierenberg AA; Fava M; Kurian BT; Warden D; Morris DW; Luther JF; Husain MM; Cook IA; Shelton RC; Lesser IM; Kornstein SG; Wisniewski SR
    Am J Psychiatry; 2011 Jul; 168(7):689-701. PubMed ID: 21536692
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Validating pre-treatment body mass index as moderator of antidepressant treatment outcomes: Findings from CO-MED trial.
    Jha MK; Wakhlu S; Dronamraju N; Minhajuddin A; Greer TL; Trivedi MH
    J Affect Disord; 2018 Jul; 234():34-37. PubMed ID: 29522941
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of antidepressant medication treatment on suicidal ideation and behavior in a randomized trial: an exploratory report from the Combining Medications to Enhance Depression Outcomes Study.
    Zisook S; Lesser IM; Lebowitz B; Rush AJ; Kallenberg G; Wisniewski SR; Nierenberg AA; Fava M; Luther JF; Morris DW; Trivedi MH
    J Clin Psychiatry; 2011 Oct; 72(10):1322-32. PubMed ID: 22075098
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Randomized comparison of selective serotonin reuptake inhibitor (escitalopram) monotherapy and antidepressant combination pharmacotherapy for major depressive disorder with melancholic features: a CO-MED report.
    Bobo WV; Chen H; Trivedi MH; Stewart JW; Nierenberg AA; Fava M; Kurian BT; Warden D; Morris DW; Luther JF; Husain MM; Cook IA; Lesser IM; Kornstein SG; Wisniewski SR; Rush AJ; Shelton RC
    J Affect Disord; 2011 Oct; 133(3):467-76. PubMed ID: 21601287
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impact of chronic depression on acute and long-term outcomes in a randomized trial comparing selective serotonin reuptake inhibitor monotherapy versus each of 2 different antidepressant medication combinations.
    Sung SC; Haley CL; Wisniewski SR; Fava M; Nierenberg AA; Warden D; Morris DW; Kurian BT; Trivedi MH; Rush AJ;
    J Clin Psychiatry; 2012 Jul; 73(7):967-76. PubMed ID: 22687487
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of concurrent substance use disorder on the effectiveness of single and combination antidepressant medications for the treatment of major depression: an exploratory analysis of a single-blind randomized trial.
    Davis LL; Pilkinton P; Wisniewski SR; Trivedi MH; Gaynes BN; Howland RH; Zisook S; Balasubramani GK; Fava M; Rush AJ
    Depress Anxiety; 2012 Feb; 29(2):111-22. PubMed ID: 22495941
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Baseline depression severity as a predictor of single and combination antidepressant treatment outcome: results from the CO-MED trial.
    Friedman ES; Davis LL; Zisook S; Wisniewski SR; Trivedi MH; Fava M; Rush AJ;
    Eur Neuropsychopharmacol; 2012 Mar; 22(3):183-99. PubMed ID: 21920711
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interleukin 17 selectively predicts better outcomes with bupropion-SSRI combination: Novel T cell biomarker for antidepressant medication selection.
    Jha MK; Minhajuddin A; Gadad BS; Greer TL; Mayes TL; Trivedi MH
    Brain Behav Immun; 2017 Nov; 66():103-110. PubMed ID: 28698115
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Depression treatment in patients with general medical conditions: results from the CO-MED trial.
    Morris DW; Budhwar N; Husain M; Wisniewski SR; Kurian BT; Luther JF; Kerber K; Rush AJ; Trivedi MH
    Ann Fam Med; 2012; 10(1):23-33. PubMed ID: 22230827
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pre-treatment insomnia as a predictor of single and combination antidepressant outcomes: a CO-MED report.
    Sung SC; Wisniewski SR; Luther JF; Trivedi MH; Rush AJ;
    J Affect Disord; 2015 Mar; 174():157-64. PubMed ID: 25497473
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reevaluating the Efficacy and Predictability of Antidepressant Treatments: A Symptom Clustering Approach.
    Chekroud AM; Gueorguieva R; Krumholz HM; Trivedi MH; Krystal JH; McCarthy G
    JAMA Psychiatry; 2017 Apr; 74(4):370-378. PubMed ID: 28241180
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Suicide ideation and male-female differences in major depressive disorder.
    Olgiati P; Pecorino B; Serretti A
    Int J Psychiatry Clin Pract; 2024 Mar; 28(1):53-62. PubMed ID: 38587055
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Does early-onset chronic or recurrent major depression impact outcomes with antidepressant medications? A CO-MED trial report.
    Sung SC; Wisniewski SR; Balasubramani GK; Zisook S; Kurian B; Warden D; Trivedi MH; Rush AJ;
    Psychol Med; 2013 May; 43(5):945-60. PubMed ID: 23228340
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adherence to antidepressant combinations and monotherapy for major depressive disorder: a CO-MED report of measurement-based care.
    Warden D; Trivedi MH; Carmody T; Toups M; Zisook S; Lesser I; Myers A; Kurian KR; Morris D; Rush AJ
    J Psychiatr Pract; 2014 Mar; 20(2):118-32. PubMed ID: 24638046
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Can C-reactive protein inform antidepressant medication selection in depressed outpatients? Findings from the CO-MED trial.
    Jha MK; Minhajuddin A; Gadad BS; Greer T; Grannemann B; Soyombo A; Mayes TL; Rush AJ; Trivedi MH
    Psychoneuroendocrinology; 2017 Apr; 78():105-113. PubMed ID: 28187400
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combination antidepressant therapy for major depressive disorder: speed and probability of remission.
    Stewart JW; McGrath PJ; Blondeau C; Deliyannides DA; Hellerstein D; Norris S; Amat J; Pilowsky DJ; Tessier P; Laberge L; O'Shea D; Chen Y; Withers A; Bergeron R; Blier P
    J Psychiatr Res; 2014 May; 52():7-14. PubMed ID: 24485847
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Irritability and Its Clinical Utility in Major Depressive Disorder: Prediction of Individual-Level Acute-Phase Outcomes Using Early Changes in Irritability and Depression Severity.
    Jha MK; Minhajuddin A; South C; Rush AJ; Trivedi MH
    Am J Psychiatry; 2019 May; 176(5):358-366. PubMed ID: 30922100
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictors of the effectiveness of an early medication change strategy in patients with major depressive disorder.
    Dreimüller N; Wagner S; Engel A; Braus DF; Roll SC; Elsner S; Tadić A; Lieb K
    BMC Psychiatry; 2019 Jan; 19(1):24. PubMed ID: 30642308
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Concise Health Risk Tracking Self-Report (CHRT-SR) assessment of suicidality in depressed outpatients: A psychometric evaluation.
    De La Garza N; Rush AJ; Killian MO; Grannemann BD; Carmody TJ; Trivedi MH
    Depress Anxiety; 2019 Apr; 36(4):313-320. PubMed ID: 30370613
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.